The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.
暂无分享，去创建一个
N. Zaffaroni | F. Zunino | C. Lanzi | G. Cassinelli | G. Petrangolini | A. Orlandi | R. Riccardi | F. Bucci | C. Pisano | V. Zuco | M. de Cesare | D. Meco | D. Passeri | D. Cominetti | M. Tortoreto | A. D. Di Francesco